Freeman Technology Unveils a New Guide to Powder Behaviour
Freeman Technology, a global leader in powder characterisation, has published a new educational guide entitled ‘An Introduction to Powders’. Written in a straightforward, easy to understand style, the new booklet explains how and why powders behave the way they do, and how this affects powder processing and characterisation. It provides a valuable foundation for those with little prior knowledge of powders, as well as being a useful resource for anyone looking to expand their understanding of the factors relevant to product development and processing performance. The booklet is now available to download free of charge via the Freeman Technology website at www.freemantech.co.uk/index.php?id=415
Powders are ubiquitous throughout industry with applications ranging from food and cosmetics to pharmaceuticals and ceramics. Understanding powder behaviour is an essential precursor to efficient processing. The new booklet, authored by Tim Freeman, Managing Director of Freeman Technology, focusses on how the three components of a powder — the particles, surrounding air and any moisture present — interact to define powder behaviour, and provides answers to the most frequently encountered powder processing issues throughout industry.
In addition to detailing the mechanisms that define powder behaviour, the new guide explores the importance of powder flowability across a range of industrial processes. It explains the significance of operational conditions in the context of powder processing and highlights direct correlations between dynamic powder properties and process performance.
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance